| Bid Price | 190.00p | High Price | 193.00p |
|---|
| Ask Price | 195.00p | Low Price | 187.50p |
|---|
| Open Price | 190.00p | Spread | 2.56% |
|---|
| Prev Close | 190.00p | Volume | 27,690 |
|---|
Faron Pharmaceuticals Oy Historic Prices
| Date | Open | High | Low | Close | Volume |
|---|
| Mar 21, 2025 | 190.00 | 195.00 | 188.86 | 190.00 | 17,647 |
| Mar 20, 2025 | 187.50 | 190.00 | 185.00 | 190.00 | 9,756 |
| Mar 19, 2025 | 185.00 | 195.00 | 186.00 | 187.50 | 10,780 |
| Mar 18, 2025 | 182.50 | 190.00 | 185.00 | 185.00 | 14,134 |
| Mar 17, 2025 | 182.50 | 185.36 | 180.00 | 182.50 | 11,585 |
Faron Pharmaceuticals Oy Information
| Name | Faron Pharmaceuticals Oy | Index | FTSE AIM 100 |
|---|
| ISIN | FI4000153309 | Epic | FARN |
|---|
| Type | Equity | Currency | GBX |
|---|
| Record Status | Active | Trading Segment | ASQ1 |
|---|
| Industry | Biotechnology | Sector | Healthcare |
|---|
| EMS | 750 | Trading Status | Closed |
|---|
| Shares in Issue | 111.60 m | Prev Close | 190.00p |
|---|
| PE Ratio | | Market Cap | £214.83 m |
|---|
| Div Yield | 0 | Div per Share | €NaN |
|---|
| EPS | -€0.09 | Div Cover | NaN |
|---|
| PEG | n/a | EPS Growth (%) | 0.00 |
|---|
| ROCE | n/a | DPS Growth (%) | 0 |
|---|
| Current Ratio | 1.087897 | Quick Ratio | 0.954085 |
|---|
Faron Pharmaceuticals Oy Director Deals
| Declared | Type | Director | Pos. | Volume / Price | Value |
|---|
| 24/06/24 | TIN | Markku Jalkanen | CEO | 16,667 @ £0.00 | £0.00 |
| 24/06/24 | TIN | Markku Jalkanen | CEO | 16,667 @ £0.00 | £0.00 |
| 24/06/24 | TIN | Yrjo Wichmann | RES | 2,333 @ £0.00 | £0.00 |
| 24/06/24 | TIN | Tuomo Patsi | NED | 6,667 @ £0.00 | £0.00 |
| 24/06/24 | PLAC | Christine Roth | NED | 46,075 @ €1.00 | €46,075.00 |
| 09/04/24 | PLAC | Markku Jalkanen | CEO | 33,333 @ £1.50 | £50,000.00 |
| 09/04/24 | BUY | Markku Jalkanen | CEO | 33,333 @ £1.50 | £50,000.00 |
| 09/04/24 | PLAC | Tuomo Patsi | NED | 13,333 @ £1.50 | £20,000.00 |
| 04/04/24 | BUY | Markku Jalkanen | CEO | 33,333 @ £1.50 | £50,000.00 |
| 04/04/24 | PLAC | Markku Jalkanen | CEO | 33,333 @ £1.50 | £50,000.00 |
Faron Pharmaceuticals Oy News
